Synokem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 4.82 Cr
as on 12-07-2024
- Company Age 41 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 147.50 Cr
as on 12-07-2024
- Satisfied Charges ₹ 14.75 Cr
as on 12-07-2024
- Revenue 12.24%
(FY 2023)
- Profit -28.92%
(FY 2023)
- Ebitda -25.21%
(FY 2023)
- Net Worth -5.26%
(FY 2023)
- Total Assets -3.80%
(FY 2023)
About Synokem Pharmaceuticals
The Corporate was formerly known as Synokem Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.82 Cr.
The company currently has active open charges totaling ₹147.50 Cr. The company has closed loans amounting to ₹14.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Synokem Pharmaceuticals Limited India are Vinay Purwar as COMPANY SECRETARY and Subhadeep Pal as Cfo. Abhinav Arora, Sanjay Khurana, Thomas Baby, and Four other members serve as directors at the Company.
- CIN/LLPIN
U34239DL1983PLC016353
- Company No.
016353
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Aug 1983
- Date of AGM
26 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Synokem Pharmaceuticals Limited offer?
Synokem Pharmaceuticals Limited offers a wide range of products and services, including Real Estate Services, Residential Property, Residential Flats, Residential Property Rentals, Serviced Apartments.
Who are the key members and board of directors at Synokem Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Arora  | Managing Director | 01-Jul-2005 | Current |
| Vinay Purwar | Company Secretary | Current | |
| Subhadeep Pal | CFO | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Khurana | Director | 10-Jan-2022 | Current |
| Thomas Baby | Director | 18-Mar-2016 | Current |
| Shubhangi Agarwal | Director | 01-Apr-2022 | Current |
| Vishal Gupta | Nominee Director | 18-Jan-2023 | Current |
| Yash Baheti | Nominee Director | 29-Mar-2023 | Current |
| Gajanan Shenoy | Director | 22-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Synokem Pharmaceuticals.
Synokem Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.24% increase. The company also saw a substantial fall in profitability, with a 28.92% decrease in profit. The company's net worth dipped by a decrease of 5.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synokem Pharmaceuticals?
In 2023, Synokem Pharmaceuticals had a promoter holding of 98.00% and a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nitin Lifesciences Limited
Active 19 years 8 monthsAbhinav Arora, Sanjay Khurana and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Jan 2024 | ₹20.00 Cr | Open |
Others Creation Date: 22 Sep 2023 | ₹115.00 Cr | Open |
Others Creation Date: 16 Feb 2009 | ₹12.50 Cr | Open |
How Many Employees Work at Synokem Pharmaceuticals?
Synokem Pharmaceuticals has a workforce of 402 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synokem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synokem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
